Sil Lutkiwitte and Randy Schrecengost will talk about their company Targepeutics and what they have done to create a protein known as GB-13 which shows great promise in the fight against DIPG and DMG.

Sil Lutkiwitte is the Chief Executive Officer and Randy Schrecengost is the Chief Scientific Officer for Targepeutics, and their company has created a protein known as GB-13 which is targeted to help in the fight against DIPG and DMG. This protein is designed to kill off bad brain cells while completely avoiding good brain cells and they are hoping to get the necessary financing to be able to bring this protein to Clinical Trial in the near future.